FcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
James R. Bateman, MD, MPH
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
B. Joy Snider, MD, PhD
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
Charles P. Vega, MD
Mastering ARIA Management: Charting the Path in a Virtual Clinic
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Thomas Karikari, PhD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Michele Longo, MD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.